Estimating the cost-effectiveness of ribavirin and pegylated interferon alfa-2B for chronic hepatitis C.

被引：0
|
作者：
Wong, JB [1 ]
机构：
[1] Tufts New England Med Ctr, Boston, MA USA
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1062
引用
下载
收藏
页码：425A / 425A
页数：1
相关论文
共 50 条
  • [11] Interferon alfa-2b and ribavirin in patients with resistant chronic hepatitis C.
    Min, AD
    Jones, JL
    Jacobson, IM
    Klion, FM
    Goldman, IS
    Esposito, S
    Geders, JM
    Tobias, H
    Bodenheimer, HC
    HEPATOLOGY, 1999, 30 (04) : 192A - 192A
  • [12] Impact of pegylated interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C.
    Poynard, T
    McHutchison, J
    Manns, M
    Trepo, C
    Lindsay, K
    Goodman, Z
    Ling, MS
    Albrecht, JK
    HEPATOLOGY, 2001, 34 (04) : 244A - 244A
  • [13] Pegylated interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C genotype
    Hasan, F
    Asker, H
    Al-Khaldi, J
    Siddique, I
    Owaid, SF
    Al-Ajmi, M
    Al-Nakib, B
    HEPATOLOGY, 2003, 38 (04) : 629A - 629A
  • [14] Cost-effectiveness of interferon alfa 2b and ribavirin in the treatment of chronic hepatitis C
    Kim, WR
    Poterucha, JJ
    Gross, JB
    HEPATOLOGY, 2000, 31 (03) : 807 - 807
  • [15] Treatment with pegylated interferon alfa-2b in combination with ribavirin improved health-related quality of life compared with interferon alfa-2b plus ribavirin in chronic hepatitis C.
    Gish, R
    Rzowej, N
    Brooks, L
    Brass, C
    Weng, W
    HEPATOLOGY, 2002, 36 (04) : 582A - 582A
  • [16] Effectiveness and tolerability of pegylated interferon alfa-2b in combination with ribavirin for treatment of chronic hepatitis C : the PegIntrust Study
    Van Vlierberghe, H.
    Adler, M.
    Bastens, B.
    Colle, I.
    Delwaide, J.
    Henrion, J.
    Horsmans, Y.
    Michielsen, P.
    Golstein, P.
    Mulkays, J. -P.
    Van Steenbergen, W.
    Yap, P.
    Nevens, F.
    Denys, A. M.
    Brasseur, J. -P.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2010, 73 (01) : 5 - 11
  • [17] Consensus Interferon and Ribavirin in Patients with Chronic Hepatitis C Who Were Nonresponders to Pegylated Interferon alfa-2b and Ribavirin
    Carroll B. Leevy
    Digestive Diseases and Sciences, 2008, 53 : 1961 - 1966
  • [18] Consensus Interferon and Ribavirin in Patients with Chronic Hepatitis C Who Were Nonresponders to Pegylated Interferon alfa-2b and Ribavirin
    Carroll B. Leevy
    Digestive Diseases and Sciences, 2008, 53 (7) : 2009 - 2009
  • [19] Consensus interferon and ribavirin in patients with chronic hepatitis c who were nonresponders to pegylated interferon alfa-2b and ribavirin
    Leevy, Carroll B.
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (07) : 1961 - 1966
  • [20] A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C
    Glue, P
    Rouzier-Panis, R
    Raffanel, C
    Sabo, R
    Gupta, SK
    Salfi, M
    Jacobs, S
    Clement, RP
    HEPATOLOGY, 2000, 32 (03) : 647 - 653
12345